Porta, M. D., Campelo, M., Santini, V., Buckstein, R., Adès, L., Sahagun, L., . . . Zeidan, A. (2025, September). C051 | PRELIMINARY EFFICACY AND SAFETY OF LUSPATERCEPT (LUSPA) INITIATED AT THE MAXIMUM APPROVED DOSE IN TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES IN THE MAXILUS STUDY. Haematologica.
Chicagoスタイル(17版)引用形式Porta, M.G. Della, et al. "C051 | PRELIMINARY EFFICACY AND SAFETY OF LUSPATERCEPT (LUSPA) INITIATED AT THE MAXIMUM APPROVED DOSE IN TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES IN THE MAXILUS STUDY." Haematologica Sep. 2025.
MLA(9版)引用形式Porta, M.G. Della, et al. "C051 | PRELIMINARY EFFICACY AND SAFETY OF LUSPATERCEPT (LUSPA) INITIATED AT THE MAXIMUM APPROVED DOSE IN TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES IN THE MAXILUS STUDY." Haematologica, Sep. 2025.